Abstracts tagged "Lean"

Abstract Number: 2484 • 2015 ACR/ARHP Annual Meeting
Use of Lean Six Sigma Methodology to Improve Time to Scheduling for New Patient Referrals to Rheumatology
Nicole Orzechowski¹, Mary Bolg², Rachael Bergeron¹, Christopher Dorman², Lauren Sanderson², Miranda Stark², Stacey Wilk² and Tammy Gray³, ¹Rheumatology, Dartmouth Hitchcock Medical Center, Lebanon, NH, ²Dartmouth Hitchcock Medical Center, Lebanon, NH, ³White River Junction Family Practice, White River Junction, VT
Background/Purpose: Patient satisfaction is an important driver of patient-centered care. The Section of Rheumatology was taking on average 5 days to contact and schedule new…
Abstract Number: 236 • 2014 ACR/ARHP Annual Meeting
Risk Factors for Prevalent and Progressive Bone Deficits Among Adult Men and Women with Cystic Fibrosis
Joshua Baker¹, Putman Melissa², Karen Herlyn³, Angela S. Pizzo⁴, Allen Lapey⁵, Joel Finklestein² and Peter A. Merkel⁶, ¹Medicine/Rheumatology, Philadelphia VA Medical Center, Philadelphia, PA, ²Harvard University, Boston, MA, ³Department of Rheumatology, University Hospital Schleswig-Holstein, Lübeck, Germany, ⁴Mercy Hospital, Portland, ME, ⁵Cystic Fibrosis Center and Division of Pediatric Pulmonology, Massachusetts General Hospital, Boston, MA, ⁶University of Pennsylvania, Philadelphia, PA
Risk Factors for Prevalent and Progressive Bone Deficits Among Adult Men and Women with Cystic FibrosisBackground/Purpose Cystic Fibrosis (CF) is associated with an increased risk…
Abstract Number: 395 • 2013 ACR/ARHP Annual Meeting
Sex Differences In Lean Mass Deficits In Rheumatoid Arthritis
Joshua Baker¹, David I. Daikh² and Patricia P. Katz³, ¹Medicine/Rheumatology, University of Pennsylvania, Philadelphia, PA, ²Rheumatology, University of California, San Francisco, San Francisco, CA, ³Medicine, University of California, San Francisco, San Francisco, CA
Background/Purpose: Significant differences in adiposity between men and women with RA have been observed (1). Another alteration of body composition, rheumatoid cachexia, characterized by low…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].